Endpoints for New Drug Approvals in AML

被引：0

作者：

Estey, Elihu ^{[1
,2
]}

机构：

[1] Univ Washington, Seattle, WA 98195 USA

[2] Fred Hutchinson Canc Res Ctr, 1124 Columbia St, Seattle, WA 98104 USA

来源：

关键词：

ACUTE MYELOID-LEUKEMIA; MINIMAL RESIDUAL DISEASE; CELL TRANSPLANTATION; COMPLETE REMISSION; 1ST; SURVIVAL; CANCER;

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：S21 / S23

页数：3

共 50 条

[1] New Endpoints, Programs Used for Drug Approvals
Rose, Suzanne
[J]. CANCER DISCOVERY, 2019, 9 (02) : 160 - 160
[2] Oncology Drug Approvals: Evaluating Endpoints and Evidence in an Era of Breakthrough Therapies
Blumenthal, Gideon M.
Kluetz, Paul G.
Schneider, Julie
Goldberg, Kirsten B.
McKee, Amy E.
Pazdur, Richard
[J]. ONCOLOGIST, 2017, 22 (07): : 762 - 767
[3] New drug approvals for 2002
Frantz, S
Smith, A
[J]. NATURE REVIEWS DRUG DISCOVERY, 2003, 2 (02) : 95 - 96
[4] NEW DRUG APPROVALS SOAR
不详
[J]. CHEMICAL & ENGINEERING NEWS, 2015, 93 (02) : 16 - 16
[5] NEW DRUG APPROVALS IN 1988
BEARY, JF
[J]. SOUTHERN MEDICAL JOURNAL, 1989, 82 (08) : 995 - 995
[6] New Drug Approvals Soar
Davidson, H. Edward
[J]. SENIOR CARE PHARMACIST, 2019, 34 (04): : 217 - 217
[7] US new drug approvals
不详
[J]. PROGRESS IN NEUROLOGY AND PSYCHIATRY, 2014, 18 (05) : 33 - 33
[8] NEW DRUG APPROVALS SPIKE
不详
[J]. CHEMICAL & ENGINEERING NEWS, 2013, 91 (01) : 11 - 11
[9] New drug approvals in oncology
Razelle Kurzrock
Hagop M. Kantarjian
Aaron S. Kesselheim
Ellen V. Sigal
[J]. Nature Reviews Clinical Oncology, 2020, 17 : 140 - 146
[10] New drug approvals for 2002
Simon Frantz
Adam Smith
[J]. Nature Reviews Drug Discovery, 2003, 2 : 95 - 96